Pepscan is a biopharmaceutical company, succesfully tackling the challenges of protein mimicry. Many proteins exert their biological activity through relatively small regions of their folded surfaces. The challenge is to reproduce these bioactive surfaces by much smaller peptides. Pepscan’s unique technology platform addresses this issue via the design and synthesis of conformationally constrained peptides with a well-defined 3D spatial structure resembling the native functional protein surface.
Pepscan Therapeutics is applying the proprietary high throughput CLIPS protein mimicking technology for the discovery and development of improved therapeutic peptides and monoclonal antibodies against intractable targets like GPCR's.
Pepscan Presto is a specialty peptide services company. Based on our state-of-the-art peptide synthesis capabilities and our profound understanding of protein-protein interactions, Pepscan Presto provides quality products and services.